Embracing Vicarious Resilience in Oncology Nursing: A Light in the Dark
The journey toward vicarious resilience is not only possible but essential—for ourselves, our patients, and it is the very essence of health care.
The journey toward vicarious resilience is not only possible but essential—for ourselves, our patients, and it is the very essence of health care.
Today, the FDA granted accelerated approval to selpercatinib (Retevmo) for pediatric patients aged 2 years and older with RET-altered advanced thyroid cancer or other solid…
An abstract is unavailable.
Thierry Facon, MD; Francesca Gay, MD, PhD; Pieter Sonneveld, MD, PhD
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
Abstract. Cancer cells exhibit phenotypical plasticity and epigenetic reprogramming, which allows them to evade lineage-dependent targeted treatments by adopting lineage plasticity. The underlying mechanisms by…
The American Society of Clinical Oncology (ASCO) annual meeting 2024 is in-person and online. The meeting offers premier scientific events for oncology professionals, patient advocates,…
Learn how Denise Casapulla, diagnosed with early breast cancer, embraced community support and redefined her value.
On May 29, 2024, the Food and Drug Administration granted accelerated approval to selpercatinib (Retevmo, Eli Lilly and Company) for pediatric patients two years of…